REGISTER for our
Welcome to our webinar on successful implementation of digital real-world studies – the 14th in the Vitaccess “Keeping it real” series.
Mark Larkin, CEO and Laura Day, Associate Director, Analytics, will be presenting on How to successfully implement a digital real-world study – sharing approaches from rare disease and oncology studies.
Vitaccess is an innovator in digital research and an established partner in real-world evidence generation. In this webinar, we will continue on from the previous webinar which covered designing a real-world study, which involves collecting global patient-level data via an app, to how to implement one. The speakers will cover driving and measuring engagement to building and executing a statistical analysis plan, through to dissemination of results.
This webinar will help you:
Understand why and how to drive and measure engagement in longitudinal studies
Build and execute SAP, including linkage analyses
Build monitoring strategy
Build effective dissemination strategy
Mark Larkin, PhD, Founder and CEO of Vitaccess
Mark founded Vitaccess with the aims of harnessing the power of digital technology to better represent the patient voice in drug development and market access, as well as collaborating with fellow experts to provide realistic, experience-based market access and HEOR consultancy.
Laura is an Associate Director in our analytics team. Her role centers on the oversight of all statistical analyses for our real-world evidence studies, study design, and reporting of analysis results to a wide range of audiences. Laura’s expertise in these areas allows clients to clearly interpret the results of our RWE studies and generate meaningful insights, therefore maximizing the value of our studies in onward applications.